These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 165045)

  • 21. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer.
    Arcangeli G; Righini R; Nervi C; Guerra A; Tirindelli D; Hopkins H; Looney W
    Cancer Treat Rep; 1985 Jan; 69(1):25-31. PubMed ID: 2981618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
    Johnson BE; Bridges JD; Sobczeck M; Gray J; Linnoila RI; Gazdar AF; Hankins L; Steinberg SM; Edison M; Frame JN; Pass H; Nesbitt J; Holden D; Mulshine JL; Glatstein E; Ihde DC
    J Clin Oncol; 1996 Mar; 14(3):806-13. PubMed ID: 8622028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer.
    Park YJ; Koh EH; Kim J; Roh JK; Chang J; Ahn CM; Sohn HY; Kim SK; Lee WY; Kim K
    Yonsei Med J; 1989; 30(1):30-7. PubMed ID: 2545051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of small cell carcinoma of the lung: therapy, staging, and biochemical markers.
    Abeloff MD; Ettinger DS; Baylin SB; Hazra T
    Cancer; 1976 Sep; 38(3):1394-401. PubMed ID: 182355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy versus chemoimmunotherapy for small-cell undifferentiated carcinoma of the lung.
    Aisner J; Wiernik PH
    Cancer; 1980 Dec; 46(12):2543-9. PubMed ID: 6256048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination chemotherapy and radiotherapy in small-cell carcinoma of the lung.
    King GA; Comis R; Ginsberg S; Goldberg J; Dale HT; Brown J; Dalal P; Chung C; Gottlieb A
    Radiology; 1977 Nov; 125(2):529-30. PubMed ID: 198846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumors.
    Livingston RB; Einhorn LH; Bodey GP; Burgess MA; Freireich EJ; Gottlieb JA
    Cancer; 1975 Aug; 36(2):327-32. PubMed ID: 50870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study.
    McCracken JD; Janaki LM; Crowley JJ; Taylor SA; Giri PG; Weiss GB; Gordon W; Baker LH; Mansouri A; Kuebler JP
    J Clin Oncol; 1990 May; 8(5):892-8. PubMed ID: 2159055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combination chemotherapy and radiation therapy for small cell carcinoma of the lung].
    Hara N; Ichinose Y; Motohiro A; Noge S; Miyake J; Ohta M; Hata K
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):80-5. PubMed ID: 3002286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S;
    J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination chemotherapy in oat cell carcinoma of the lung.
    Nixon DW; Carey RW; Suit HD; Aisenberg AC
    Cancer; 1975 Sep; 36(3):867-72. PubMed ID: 171056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
    Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK
    Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oat cell carcinoma of the lung. Early treatment results of combination radiation therapy and chemotherapy.
    Hornback NB; Einhorn L; Shidnia H; Joe BT; Krause M; Furnas B
    Cancer; 1976 Jun; 37(6):2658-64. PubMed ID: 181121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of two combination chemotherapies for the treatment of small cell carcinoma of the lung.
    Kutsuzawa T; Hayashi Y; Kurata T; Kobayashi R; Kondo T; Sonoda Y; Takasaki Y; Shioya S; Yamauchi T; Tamaya S
    Tokai J Exp Clin Med; 1984 Dec; 9(5-6):363-9. PubMed ID: 6100629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cyclophosphamide, adriamycin and vincristine (CAV) in the treatment of small cell lung cancer].
    Kawahara M; Tsuruta M; Furuse K; Arai R; Kodama N; Yamamoto M; Kubota K; Nakai R; Ogawara M
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):457-62. PubMed ID: 2831819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternating chemotherapy with cyclophosphamide/adriamycin/vincristine (CAV) and cisplatin/etoposide (PVP) against small cell lung cancer. Eastern Shikoku Lung Cancer Chemotherapy Group.
    Bando H; Takishita Y; Ogura T; Sone S; Shimizu E; Nakayama T; Doi H; Kobayashi M
    Jpn J Clin Oncol; 1991 Dec; 21(6):435-9. PubMed ID: 1666660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study.
    Kies MS; Mira JG; Crowley JJ; Chen TT; Pazdur R; Grozea PN; Rivkin SE; Coltman CA; Ward JH; Livingston RB
    J Clin Oncol; 1987 Apr; 5(4):592-600. PubMed ID: 3031226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined therapy for small cell undifferentiated carcinoma of the lung.
    Mandelbaum I; Williams SD; Hornback NB; Joe BT; Einhorn LH
    J Thorac Cardiovasc Surg; 1978 Sep; 76(3):292-6. PubMed ID: 210332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
    Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
    Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group.
    Hong WK; Nicaise C; Lawson R; Maroun JA; Comis R; Speer J; Luedke D; Hurtubise M; Lanzotti V; Goodlow J
    J Clin Oncol; 1989 Apr; 7(4):450-6. PubMed ID: 2538577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.